Phibro Animal Health | PAHC - Заемный капитал





Заемный капитал Изменить Дата
Align Technology USD 0 0 2024-12
ANI Pharmaceuticals USD 280.15M 5.84M 2026-06
Aurora Cannabis CAD 18.13M 15.07M 2026-03
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Canopy Growth CAD 217.12M 7.87M 2026-03
Eli Lilly USD 47.86B 8.49B 2026-06
Henry Schein USD 2.3B 27M 2026-06
Idexx Laboratories USD 299.86M 11K 2026-06
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Merck USD 51.08B 4.41B 2026-06
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Pacira USD 363.12M 4.53M 2026-06
Phibro Animal Health USD 597.68M 5.92M 2026-03
Prestige Brands USD 2.02B 1.01B 2026-06
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Zoetis USD 9.05B 3M 2026-06